Intra-Cellular Therapies
ITCI
#1493
Rank
โ‚ฌ11.95 B
Marketcap
112,27ย โ‚ฌ
Share price
0.00%
Change (1 day)
72.61%
Change (1 year)

Intra-Cellular Therapies (ITCI) Fails to deliver data

Key failure to deliver metrics for Intra-Cellular Therapies:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Intra-Cellular Therapies (ITCI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Intra-Cellular Therapies (ITCI) - since 2014

Volume in USD (price x number of shares), data since 2014

Intra-Cellular Therapies (ITCI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ0.13 B426.56%
2024โ‚ฌ24.89 M-40.94%
2023โ‚ฌ42.15 M51.56%
2022โ‚ฌ27.81 M16.21%
2021โ‚ฌ23.93 M25.98%
2020โ‚ฌ18.99 M-33.46%
2019โ‚ฌ28.54 M2213.17%
2018โ‚ฌ1.23 M-95.97%
2017โ‚ฌ30.59 M29.42%
2016โ‚ฌ23.63 M-65.91%
2015โ‚ฌ69.33 M104.09%
2014โ‚ฌ33.97 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
MediciNova
MNOV
โ‚ฌ1.03 Mโ‚ฌ1.08 M๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚ฌ0 Mโ‚ฌ0.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.23 Mโ‚ฌ0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA